Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85α Src homology-2 domains
暂无分享,去创建一个
[1] H. Niiro,et al. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway. , 2000, Immunological reviews.
[2] S. Harrison,et al. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes , 1996, Nature Structural Biology.
[3] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[4] Ji Luo,et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.
[5] K. Kinzler,et al. A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane , 2009, Proceedings of the National Academy of Sciences.
[6] J. Schlessinger,et al. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. , 1998, The EMBO journal.
[7] D. Kioussis,et al. Insulin Induces SOCS-6 Expression and Its Binding to the p85 Monomer of Phosphoinositide 3-Kinase, Resulting in Improvement in Glucose Metabolism* , 2004, Journal of Biological Chemistry.
[8] Roger L. Williams,et al. Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism , 2011, Molecular cell.
[9] T. Pawson,et al. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. , 2006, Molecular cell.
[10] Kohjiro Ueki,et al. Molecular Balance between the Regulatory and Catalytic Subunits of Phosphoinositide 3-Kinase Regulates Cell Signaling and Survival , 2002, Molecular and Cellular Biology.
[11] Zhou Songyang,et al. Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.
[12] S. Hirohashi,et al. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer. , 2009, Cancer letters.
[13] Mario Mellado,et al. Role of the Pi3k Regulatory Subunit in the Control of Actin Organization and Cell Migration , 2000, The Journal of cell biology.
[14] J. Backer,et al. Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit , 1998, Molecular and Cellular Biology.
[15] J. Klein,et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. , 2003, The Journal of biological chemistry.
[16] Zhou Songyang,et al. Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes* , 1997, The Journal of Biological Chemistry.
[17] J. Engelman,et al. Biochemistry. PI3K charges ahead. , 2007, Science.
[18] J. Schlessinger,et al. Activation of phospholipase Cγ by PI 3‐kinase‐induced PH domain‐mediated membrane targeting , 1998 .
[19] M. D. Chamberlain,et al. The p85α Subunit of Phosphatidylinositol 3′-Kinase Binds to and Stimulates the GTPase Activity of Rab Proteins* , 2004, Journal of Biological Chemistry.
[20] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[21] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[22] J. Klein,et al. Positive and Negative Roles of p85α and p85β Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling* , 2003, Journal of Biological Chemistry.
[23] Yuval Inbar,et al. Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit , 2007, Science.
[24] Lewis C Cantley,et al. A rapid method for determining protein kinase phosphorylation specificity , 2004, Nature Methods.
[25] L. Cantley,et al. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. , 1993, The Journal of biological chemistry.
[26] V. Sánchez-Margalet,et al. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K , 1999, FEBS letters.
[27] T. Takenawa,et al. Highly conserved eight amino acid sequence in SH2 is important for recognition of phosphotyrosine site. , 1991, Biochemical and biophysical research communications.
[28] A. Tomassetti,et al. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells , 2009, Oncogene.
[29] Bert Vogelstein,et al. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. , 2007, Science.
[30] A. Breeze,et al. Structure of a specific peptide complex of the carboxy‐terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3‐kinase. , 1996, The EMBO journal.
[31] Bert Vogelstein,et al. The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations , 2007, Science.
[32] E. Rozengurt,et al. Protein Kinase D Signaling* , 2005, Journal of Biological Chemistry.